SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing strong community interest driven by anticipation for upcoming government contract announcements, positive analyst sentiment, and expansion into its new Colorado headquarters. Investors are actively discussing the company's neutral-atom technology and potential sector rotation as a key advantage over competitors in the quantum space.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors draw parallels between recent positive Phase 3 cancer vaccine data from Moderna and the upcoming pivotal readout for the REGAL trial, fueling heavy speculation about potential buyout interest. The community is actively discussing the stock's high short interest and the anticipation of trial results that could validate its immune-based oncology platform.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is experiencing high volatility as investors react to a broader data-center sector sell-off, despite strong institutional backing and optimistic long-term growth narratives. The community is actively debating whether the sharp price swings are due to institutional manipulation and algorithmic trading or temporary regulatory headwinds in Texas.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense trading activity as bulls celebrate its strong performance and expansion in sovereign AI, while short sellers remain vocal despite significant losses. Community members are actively debating the stock's valuation, recent contract wins, and the sustainability of its momentum.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are experiencing intense volatility as investors debate the long-term potential of its cancer vaccine data, with community sentiment split between bullish enthusiasm over the breakthrough and bearish skepticism regarding the stock's valuation and potential for share dilution. The conversation is heavily focused on whether the clinical success justifies the recent price surge or if it represents a short-lived rally.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is rallying after fully commercializing its Beacon Point data center campus with a new 15-year, $9.8 billion lease, effectively doubling its contracted IT capacity. Investors are cheering the expansion as a validation of the company's pivot from crypto mining to high-demand AI infrastructure, though some market participants remain cautious about potential profit-taking following the pre-market surge.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is trending as investors focus on the company's aggressive pivot toward AI infrastructure and high-capacity data centers, with community members actively discussing a potential short squeeze amid strong revenue growth. Bulls are closely watching key technical resistance levels while debating the impact of the Northern Data acquisition and the anticipated announcement of major hyperscaler contracts.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is facing heightened volatility as investors weigh the potential of its long-term Anthropic data center partnership against broader sector pressure and concerns over high short interest. Community sentiment remains polarized, with many retail traders accusing market makers of manipulation and naked shorting, while others argue that the current price levels represent a strategic accumulation opportunity ahead of future earnings and IPO milestones.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is trending as investors await its upcoming earnings report, with community members debating the company's strategic pivot toward AI data center operations and its recent long-term lease agreement. Despite volatility and bearish sentiment regarding management, supporters point to the potential for a short squeeze and long-term value in the company's power infrastructure.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as it hits new 52-week highs, driven by strong quarterly revenue, improved manufacturing margins, and bullish analyst sentiment regarding the commercial progress of Amtagvi. Retail investors are fueling an extremely bullish sentiment, with widespread discussions focusing on high short interest, the potential for a short squeeze, and optimism surrounding the upcoming lung cancer trial data as a major valuation catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


789clubluxury

789club